ANDERSON ERRIK 13D/13G Filings for Compass Therapeutics, Inc. (CMPX)

ANDERSON ERRIK 13D and 13G filings for Compass Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-12-17
3:14 pm
Purchase
2021-12-17 13G Compass Therapeutics, Inc.
CMPX
ANDERSON ERRIK 3,546,730
3.600%
3,546,730increase
(New Position)
Filing